949 Combined Perioperative Colchicine for Prevention of Postoperative Atrial Fibrillation in Coronary Revascularization: A Systematic Review and Meta Analysis of Randomized Controlled Trials
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.159 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von A L Anusha Vijayanand und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Postoperative atrial fibrillation (POAF) occurs in 10-65% of patients following coronary revascularization representing a significant and prevalent complication. The anti-inflammatory drug, colchicine, has been found to prevent POAF. This review aims to evaluate the efficacy and safety of perioperative colchicine vs. placebo for preventing POAF in patients undergoing coronary revascularization.
Method
This review was registered on PROSPERO (ID: 1243671). A systematic search of PubMed, CENTRAL, and Clinicaltrials.gov in compliance with PRISMA guidelines was conducted from inception to November 2025. Eligible randomized controlled trials included adults undergoing coronary revascularization and reported the primary outcome of POAF in patients randomized to colchicine versus placebo. All quantitative analysis was performed in R (v4.5.1).
Results
Of the screened studies, four randomized control trials (n = 676 patients) met inclusion criteria. Across the four, colchicine was associated with consistent reduction in POAF. Study-level risk ratios ranged from 0.22 to 0.54. In the fixed-effect model, colchicine reduced risk of POAF by 54% (RR 0.46, 95% CI 0.32–0.67; p < 0.0001). The random-effects model produced a nearly identical estimate (RR 0.47, 95% CI 0.33–0.67; p = 0.0069), reflecting high consistency of results across trials. Heterogeneity was negligible (I² = 0%, τ² = 0; Q = 1.07, p = 0.79) and the funnel plot was symmetrical indicating minimal publication bias although our analysis remains limited by the small number of studies included.
Conclusions
Overall, colchicine demonstrated a robust reduction in the incidence of POAF across the existing literature and presents considerable benefit to reduce postoperative arrhythmogenic burden.
Zitieren
APA
Vijayanand, A. L. A., Kundur, S. P., Batti, L. W., Idham, R. A. B. N., Khan, M. A. R., Malik, A., Mansour, H. R. K., Rai, A., & Sivalokanathan, S. (2026). 949 Combined Perioperative Colchicine for Prevention of Postoperative Atrial Fibrillation in Coronary Revascularization: A Systematic Review and Meta Analysis of Randomized Controlled Trials. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.159
Vancouver
Vijayanand ALA, Kundur SP, Batti LW, Idham RABN, Khan MAR, Malik A, et al. 949 Combined Perioperative Colchicine for Prevention of Postoperative Atrial Fibrillation in Coronary Revascularization: A Systematic Review and Meta Analysis of Randomized Controlled Trials. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.159
BibTeX
@article{Vijayanand2026,
author = {Vijayanand, A L Anusha and Kundur, S Pradeep and Batti, L Wadii and Idham, R A Binte Nor and Khan, M A R and Malik, A and Mansour, H Reza Khademi and Rai, A and Sivalokanathan, S},
title = {949 Combined Perioperative Colchicine for Prevention of Postoperative Atrial Fibrillation in Coronary Revascularization: A Systematic Review and Meta Analysis of Randomized Controlled Trials},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.159}
}
EUVIMED